Prevalence of KRAS and NRAS mutations in patients with metastatic colorectal cancer in Argentina: A multicenter prospective observational study.
Gabriela Marechal, Ignacio Casarini, Astegiano Mario Gabriel Gabriel, A. Pini et autres
e15608 Background: Analysis of RAS mutations in specific populations is important as it is a predictive biomarker in the selection of RAS WT patients for treatment with EGFRI(s). There are currently no robust RAS (KRAS and NRAS) mutation data available for Argentinian …
ar, us (code pays fourni par la source)
0 citations
Journal of Clinical Oncology